To: jeffbas who wrote (286 ) 10/30/1997 2:15:00 PM From: kolo55 Respond to of 1250
I am disappointed with the comment you got from the CFO. I think they must have been hoping to get that big shipment out in time to "save" the quarter. But I must tell you, the management of ACTM has never been kind to the individual investor. When I first began researching this sector it was the hardest company to get information on. There was some kind of delay in getting their previous reports published on the SEC edgar site, the earnings releases were delayed to almost the last possible day and weren't widely disseminated, and the earnings reports were extremely sketchy. I really thought at one time, the management was trying to keep the stock a "secret" since management seemed to be acquiring shares from time to time. But in fairness, this stock has been the playground of momentum investors, and I think the stock is going through a process of moving to longer term value or GARP investors. Good riddance to the Mo guys, even though I don't think the stock will ever attain the high PE it had at 48 in August; now the company has shown it can disappoint, the constantly rising revenues/earnings that turn the mo guys on, just can't always be counted on. But for a relatively small ECM company, there will always be the possibility of a surprise shortfall. The margins are low, and any significant customer turnover will impact earnings. We've seen case after case of this in this sector over the last several years. It happened to Jabil in early 96, Flextronics in mid-96, and is happening to Hadco and Elamex right now (both are losing large customers moving to Asia). I believe these "predictable surprises" create buying opportunities. Earlier this year I tried to explain that in my posts on Elexsys and Flextronics. Occasionally I get it wrong, like in the case of Smartflex, where I misunderstood the trends in the hard drive industry, where their major customers were located. But all in all, buying these stocks when they announce short term problems, has been a profitable strategy (see FLEXF, DIIG, ELEX, BHE, AFLX this past year). In the case of ACTM, I think the company is being forced to rethink their strategy a bit. I like the move to concentrate in some medical systems assembly, in which the acquisition of the Georgia company seems to be part of this effort. Also I like the moves to expand in Ireland and bring in the Stanley business. As the company becomes less reliant on Massachusetts networkers, I think the risk of these surprises declines. I always felt this stock should carry a risk premium as long as it was basically a one industry one location stock. The current price looks very good to me. The revenues from last quarter's missed shipment should turn up this quarter, and so I expect this quarter the company should see a return to reasonable profitability in the current quarter. And next year I still see $1.60 to $2.00 in earnings. I don't think management will be able to grow this company faster than the sector (25-30%) like they talk about, but the stock is priced as though the company's earnings will be flat over the next several years. This is a very low expectation to beat, and I think they can do it handily. I expect to see this stock in the mid-30s or higher in one year. The downside isn't much lower than where te stock is this morining. For the patient investor, this risk/reward looks good to me. I bought more shares this morining, and now hold 8200 shares. Paul